CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

House bill aims to crack down on China biotech deals

RegulatoryNegative
AI Analysis

Summary

A House bill proposes adding biotechnology to the COINS Act to restrict China biotech deals, following major transactions involving Pfizer and Bristol Myers, amid U.S. national security concerns over China's pharmaceutical advancement.

Importance:4/10
Sentiment:
-0.60
regulatorygeopoliticsChinabiotechlegislationM&A
Related Companies

Read the original article

Published by BioPharma Dive on June 3, 2026 3:18 PM

Read Original